.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Novartis
Merck
US Army
Daiichi Sankyo
AstraZeneca
QuintilesIMS
Boehringer Ingelheim
Citi
Queensland Health

Generated: July 23, 2017

DrugPatentWatch Database Preview

Cefditoren pivoxil - Generic Drug Details

« Back to Dashboard

What are the generic sources for cefditoren pivoxil and what is the scope of cefditoren pivoxil freedom to operate?

Cefditoren pivoxil
is the generic ingredient in one branded drug marketed by Vansen Pharma and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Cefditoren pivoxil has seventeen patent family members in fifteen countries.

There are six drug master file entries for cefditoren pivoxil. Two suppliers are listed for this compound.

Summary for Generic Name: cefditoren pivoxil

Tradenames:1
Patents:1
Applicants:1
NDAs:1
Drug Master File Entries: see list6
Suppliers / Packagers: see list2
Bulk Api Vendors: see list27
Clinical Trials: see list3
Patent Applications: see list792
Therapeutic Class:Antibacterials
Drug Prices:see low prices
DailyMed Link:cefditoren pivoxil at DailyMed

Pharmacology for Ingredient: cefditoren pivoxil

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vansen Pharma
SPECTRACEF
cefditoren pivoxil
TABLET;ORAL021222-002Jul 21, 2008DISCNNoNo5,958,915► SubscribeY ► Subscribe
Vansen Pharma
SPECTRACEF
cefditoren pivoxil
TABLET;ORAL021222-001Aug 29, 2001DISCNNoNo5,958,915► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: cefditoren pivoxil

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Vansen Pharma
SPECTRACEF
cefditoren pivoxil
TABLET;ORAL021222-002Jul 21, 20085,958,915► Subscribe
Vansen Pharma
SPECTRACEF
cefditoren pivoxil
TABLET;ORAL021222-001Aug 29, 20014,839,350► Subscribe
Vansen Pharma
SPECTRACEF
cefditoren pivoxil
TABLET;ORAL021222-001Aug 29, 20015,958,915► Subscribe
Vansen Pharma
SPECTRACEF
cefditoren pivoxil
TABLET;ORAL021222-002Jul 21, 20084,839,350► Subscribe
Vansen Pharma
SPECTRACEF
cefditoren pivoxil
TABLET;ORAL021222-001Aug 29, 20014,918,068► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: cefditoren pivoxil

Country Document Number Estimated Expiration
Spain2174109► Subscribe
Mexico9802849► Subscribe
European Patent Office0862915► Subscribe
Germany69620220► Subscribe
Taiwan458778► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Fish and Richardson
Fuji
QuintilesIMS
Cipla
Colorcon
Daiichi Sankyo
Johnson and Johnson
Baxter
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot